Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)
March 05 2018 - 4:36PM
Edgar (US Regulatory)
March 5, 2018
U.S.
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
|
Re:
|
Notice of disclosure filed in Annual Report on Form
20-F
pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of
the Securities Exchange Act of 1934, as amended
|
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange
Act of 1934, as amended, notice is hereby provided that Capital Product Partners L.P. has made disclosure pursuant to those provisions in its Annual Report on Form
20-F
for the year ended December 31,
2017, which was filed with the U.S. Securities and Exchange Commission on March 5, 2018.
Respectfully submitted,
|
|
|
|
|
CAPITAL PRODUCT PARTNERS L.P.
|
|
|
|
|
By:
|
|
Capital GP L.L.C., its general partner
|
|
|
|
|
By:
|
|
/s/ Gerasimos (Jerry) Kalogiratos
|
|
Name:
|
|
Gerasimos (Jerry) Kalogiratos
|
|
Title:
|
|
Chief Executive Officer of Capital GP L.L.C.
|
Capital Product Partners (NASDAQ:CPLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Capital Product Partners (NASDAQ:CPLP)
Historical Stock Chart
From Apr 2023 to Apr 2024
